NewAmsterdam Pharma Company NV at Citi Global Healthcare Conference Transcript
(technical difficulty) Global Health Conference at Citi. My name is Geoff Meacham. I am the Head of Healthcare, Global Head of Biotech Pharma Research. Fun, fun. We're thrilled today to have NewAmsterdam Pharma.
We have Michael Davidson, CEO; we have Ian Somaiya, CFO. Guys, thanks a lot for the time.
Thanks, Geoff.
So maybe we'll just do like a quick background, Michael, you want to give like a couple of minute like pitch just sort of elevator, then we get into some PREVAIL questions, marketing.
Sure. I mean this has been a great year, 2025. We announced at the end of last year in 2024, our BROADWAY Phase 3 -- completed our 3 Phase 3 trials, which will be for the submission for regulatory approval across the world.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
